A Study to Assess Adults With CIDP Transitioning From IVIg to Efgartigimod PH20 SC
Public ClinicalTrials.gov record NCT06637072. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 4, Open-Label, Single-Group, Multicenter Study in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy Who Transition From Treatment With Intravenous Immunoglobulin to Efgartigimod PH20 SC
Study identification
- NCT ID
- NCT06637072
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- argenx
- Industry
- Enrollment
- 23 participants
Conditions and interventions
Interventions
- Efgartigimod PH20 SC Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 9, 2024
- Primary completion
- Feb 18, 2026
- Completion
- Feb 18, 2026
- Last update posted
- Apr 5, 2026
2024 – 2026
United States locations
- U.S. sites
- 13
- U.S. states
- 8
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| MedStar Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | — |
| Neurology Associates PA | Maitland | Florida | 32751 | — |
| Visionary Investigators Network | Miami | Florida | 33180 | — |
| Northwestern Memorial Hospital | Chicago | Illinois | 60611 | — |
| Velocity Clinical Research | Lafayette | Louisiana | 70508 | — |
| SRI International - ClinEdge | Plymouth | Michigan | 48170 | — |
| Velocity Clinical Research | Raleigh | North Carolina | 27607 | — |
| Erlanger Neuroscience Institute | Chattanooga | Tennessee | 37403 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
| National Neuromuscular Research Institute | Austin | Texas | 78759 | — |
| Horizon Clinical Research: Gill Neuroscience | Cypress | Texas | 21216 | — |
| Northwest Houston Neurology - Cypress | Cypress | Texas | 77429 | — |
| Cedar Health Research - Dallas | Dallas | Texas | 75251 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06637072, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 5, 2026 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06637072 live on ClinicalTrials.gov.